ADVFN ADVFN

Hot Features

Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
ZyVersa Therapeutics Inc (QB)

ZyVersa Therapeutics Inc (QB) (ZVSA)

0.16945
-0.02545
(-13.06%)
終了 6月18日 5:00AM

ZyVersa Therapeutics Inc (QB) (ZVSA) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
0.16945
( -13.06% )
買値
0.1611
売値
0.1946
出来高
16,825
0.161 日の範囲 0.1949
0.11 52 週間の範囲 0.3113
時価総額
前日終値
0.1949
始値
0.1949
最終取引時間
財務取引量
US$ 2,821
VWAP
0.167694
平均取引量 (3 か月)
US$ 18,384
発行済株式数
8,095,921
配当利回り
PER
-0.05
1 株当たり利益 (EPS)
-3.39
歳入
-
純利益
-24.49M

ZyVersa Therapeutics Inc (QB) について

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It develops drug development platforms, including Cholesterol Efflux Mediator VAR 200, an injectable drug, which is in Phase 2a clinical ... ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It develops drug development platforms, including Cholesterol Efflux Mediator VAR 200, an injectable drug, which is in Phase 2a clinical trial for the treatment of renal indications, such as focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney diseases; and Inflammasome ASC Inhibitor IC 100 a humanized monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of numerous inflammatory diseases, with cardiometabolic conditions associated with obesity as the lead. The company has a license agreement with L&F Research LLC, and InflamaCORE, LLC. ZyVersa Therapeutics, Inc. was founded in 2014 and is based in Weston, Florida. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Weston, United States
設立
2026
ZyVersa Therapeutics Inc (QB) is listed in the Healthcare sector of the その他OTC with ticker ZVSA. The last closing price for ZyVersa Therapeutics (QB) was US$0.19. Over the last year, ZyVersa Therapeutics (QB) shares have traded in a share price range of US$ 0.11 to US$ 0.3113.

ZyVersa Therapeutics (QB) currently has 8,095,921 shares in issue. The market capitalisation of ZyVersa Therapeutics (QB) is US$1.37 million. ZyVersa Therapeutics (QB) has a price to earnings ratio (PE ratio) of -0.05.

ZVSA 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.00545-3.116066323610.17490.19990.161114600.19056763CS
4-0.03325-16.40355204740.20270.21390.16177220.18946442CS
12-0.05055-22.97727272730.220.23670.16105790.1983462CS
260.0361527.119279820.13330.30.1257434460.21151636CS
520.014859.605433376460.15460.31130.11618920.18715615CS
1560.014859.605433376460.15460.31130.11618920.18715615CS
2600.014859.605433376460.15460.31130.11618920.18715615CS

ZVSA - Frequently Asked Questions (FAQ)

What is the current ZyVersa Therapeutics Inc (QB) share price?
The current share price of ZyVersa Therapeutics Inc (QB) is US$ 0.16945
How many ZyVersa Therapeutics Inc (QB) shares are in issue?
ZyVersa Therapeutics Inc (QB) has 8,095,921 shares in issue
What is the market cap of ZyVersa Therapeutics Inc (QB)?
The market capitalisation of ZyVersa Therapeutics Inc (QB) is USD 1.37M
What is the 1 year trading range for ZyVersa Therapeutics Inc (QB) share price?
ZyVersa Therapeutics Inc (QB) has traded in the range of US$ 0.11 to US$ 0.3113 during the past year
What is the PE ratio of ZyVersa Therapeutics Inc (QB)?
The price to earnings ratio of ZyVersa Therapeutics Inc (QB) is -0.05
What is the registered address of ZyVersa Therapeutics Inc (QB)?
The registered address for ZyVersa Therapeutics Inc (QB) is 2200 N. Commerce Parkway, Weston, Florida, 33326
What is the ZyVersa Therapeutics Inc (QB) website address?
The website address for ZyVersa Therapeutics Inc (QB) is www.zyversa.com
Which industry sector does ZyVersa Therapeutics Inc (QB) operate in?
ZyVersa Therapeutics Inc (QB) operates in the Biotechnology & Life Sciences sector

ZVSA 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock